These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A review of the use of modafinil for attention-deficit hyperactivity disorder. Turner D. Expert Rev Neurother; 2006 Apr; 6(4):455-68. PubMed ID: 16623645 [Abstract] [Full Text] [Related]
3. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH, Zacharek M, Musial J. J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853 [Abstract] [Full Text] [Related]
5. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S. Psychiatry Res; 2009 Aug 15; 168(3):234-7. PubMed ID: 19439364 [Abstract] [Full Text] [Related]
7. [Pharmacological treatment of amphetamine dependence still on unsafe basis]. Franck J. Lakartidningen; 2009 Aug 15; 108(45):2304-7. PubMed ID: 22242247 [No Abstract] [Full Text] [Related]